ES2042371B1 - PROCESS AND EQUIPMENT FOR THE DETECTION OF STORAGE DRUGS IN DRUG TRAFFICKING. - Google Patents
PROCESS AND EQUIPMENT FOR THE DETECTION OF STORAGE DRUGS IN DRUG TRAFFICKING.Info
- Publication number
- ES2042371B1 ES2042371B1 ES9101471A ES9101471A ES2042371B1 ES 2042371 B1 ES2042371 B1 ES 2042371B1 ES 9101471 A ES9101471 A ES 9101471A ES 9101471 A ES9101471 A ES 9101471A ES 2042371 B1 ES2042371 B1 ES 2042371B1
- Authority
- ES
- Spain
- Prior art keywords
- cocaina
- drugs
- detection
- equipment
- steps
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229940079593 drug Drugs 0.000 title abstract 4
- 239000003814 drug Substances 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 238000001514 detection method Methods 0.000 title 1
- 230000032258 transport Effects 0.000 title 1
- -1 AMITRIPTILINE Chemical compound 0.000 abstract 3
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 abstract 3
- FTOAOBMCPZCFFF-UHFFFAOYSA-N 5,5-diethylbarbituric acid Chemical compound CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 abstract 2
- DEXMFYZAHXMZNM-UHFFFAOYSA-N Narceine Chemical compound OC(=O)C1=C(OC)C(OC)=CC=C1C(=O)CC1=C(CCN(C)C)C=C(OCO2)C2=C1OC DEXMFYZAHXMZNM-UHFFFAOYSA-N 0.000 abstract 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 abstract 2
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 abstract 1
- YJYRIVVGIRCAHD-UHFFFAOYSA-N 1-bromoazepane Chemical compound BrN1CCCCCC1 YJYRIVVGIRCAHD-UHFFFAOYSA-N 0.000 abstract 1
- USSIQXCVUWKGNF-UHFFFAOYSA-N 6-(dimethylamino)-4,4-diphenylheptan-3-one Chemical compound C=1C=CC=CC=1C(CC(C)N(C)C)(C(=O)CC)C1=CC=CC=C1 USSIQXCVUWKGNF-UHFFFAOYSA-N 0.000 abstract 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 abstract 1
- VAYOSLLFUXYJDT-RDTXWAMCSA-N Lysergic acid diethylamide Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N(CC)CC)C2)=C3C2=CNC3=C1 VAYOSLLFUXYJDT-RDTXWAMCSA-N 0.000 abstract 1
- CYQFCXCEBYINGO-UHFFFAOYSA-N THC Natural products C1=C(C)CCC2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3C21 CYQFCXCEBYINGO-UHFFFAOYSA-N 0.000 abstract 1
- VIROVYVQCGLCII-UHFFFAOYSA-N amobarbital Chemical compound CC(C)CCC1(CC)C(=O)NC(=O)NC1=O VIROVYVQCGLCII-UHFFFAOYSA-N 0.000 abstract 1
- 229940025084 amphetamine Drugs 0.000 abstract 1
- 229960002319 barbital Drugs 0.000 abstract 1
- RMRJXGBAOAMLHD-IHFGGWKQSA-N buprenorphine Chemical compound C([C@]12[C@H]3OC=4C(O)=CC=C(C2=4)C[C@@H]2[C@]11CC[C@]3([C@H](C1)[C@](C)(O)C(C)(C)C)OC)CN2CC1CC1 RMRJXGBAOAMLHD-IHFGGWKQSA-N 0.000 abstract 1
- LRXXRIXDSAEIOR-ZDUSSCGKSA-N clobenzorex Chemical compound C([C@H](C)NCC=1C(=CC=CC=1)Cl)C1=CC=CC=C1 LRXXRIXDSAEIOR-ZDUSSCGKSA-N 0.000 abstract 1
- 229960002492 clobenzorex Drugs 0.000 abstract 1
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 abstract 1
- 229960004242 dronabinol Drugs 0.000 abstract 1
- 229960002456 hexobarbital Drugs 0.000 abstract 1
- UYXAWHWODHRRMR-UHFFFAOYSA-N hexobarbital Chemical compound O=C1N(C)C(=O)NC(=O)C1(C)C1=CCCCC1 UYXAWHWODHRRMR-UHFFFAOYSA-N 0.000 abstract 1
- BCGWQEUPMDMJNV-UHFFFAOYSA-N imipramine Chemical compound C1CC2=CC=CC=C2N(CCCN(C)C)C2=CC=CC=C21 BCGWQEUPMDMJNV-UHFFFAOYSA-N 0.000 abstract 1
- 229960004801 imipramine Drugs 0.000 abstract 1
- 229960004194 lidocaine Drugs 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 229950002454 lysergide Drugs 0.000 abstract 1
- 229960001797 methadone Drugs 0.000 abstract 1
- 229960005181 morphine Drugs 0.000 abstract 1
- 238000006452 multicomponent reaction Methods 0.000 abstract 1
- VOKSWYLNZZRQPF-GDIGMMSISA-N pentazocine Chemical compound C1C2=CC=C(O)C=C2[C@@]2(C)[C@@H](C)[C@@H]1N(CC=C(C)C)CC2 VOKSWYLNZZRQPF-GDIGMMSISA-N 0.000 abstract 1
- 229960005301 pentazocine Drugs 0.000 abstract 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 abstract 1
- 229960004919 procaine Drugs 0.000 abstract 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
LA PRESENTE INVENCION, SE REFIERE A UNA SERIE DE PROCESOS PARA LA IDENTIFICACION DE DROGAS DE ALIJO EN NARCOTRAFICO, PRESUMIBLEMENTE: AMITAL, AMITRIPTILINA, ANFETAMINA, BARBITAL, BROMAZEPAN, BUPRENORFINA, CLOBENZOREX, COCAINA, CODEINA, DIAZEPAN, HEROINA BLANCA, HEROINA SUGAR BROWN, HEXOBARBITAL, IMIPRAMINA, LIDOCAINA, LSD, METACUALONA, METADONA, MORFINA, NARCEINA, NITRAZEPAN, NORTRIPTILINA, PENTAZOCINA, PROCAINA Y TETRAHIDROCANNABINOL. ESTOS EQUIPOS MEDIANTE TEST PERMITEN A LOS OFICIALES DE POLICIA DETECTAR PRESUMIBLEMENTE LA EXISTENCIA DE DROGAS CUANDO NO ES POSIBLE HACERLO A TRAVES DE UN LABORATORIO, DICHO PROCESO COMPRENDE LOS SIGUIENTES PASOS: 1.BSO SC) PRESUMIBLE IDENTIFICACION DE UNA DROGA DESCONOCIDA MEDIANTE EL USO DE REACCIONES UNICOMPONENTES (EN 1 SOLO PASO) O MEDIANTE REACCIONES MULTICOMPONENTES (EN 2 O 3 PASOS),THE PRESENT INVENTION REFERS TO A SERIES OF PROCESSES FOR THE IDENTIFICATION OF LIQUID DRUGS IN NARCO-TRAFFICKING, PRESUMABLY: AMITAL, AMITRIPTILINE, AMPHETAMINE, BARBITAL, BROMAZEPAN, BUPRENORFINA, CLOBENZOREX, COCAINA, CODE, COCAINA, COCAINA HEXOBARBITAL, IMIPRAMINE, LIDOCAINE, LSD, METACUALONE, METADONE, MORPHINE, NARCEINE, NITRAZEPAN, NORTRIPTILINE, PENTAZOCINE, PROCAINE AND TETRAHYDROCANNABINOL. THESE TEAMS THROUGH TEST ALLOW POLICE OFFICERS TO PRESUMPULARLY DETECT THE EXISTENCE OF DRUGS WHEN IT IS NOT POSSIBLE TO DO SO THROUGH A LABORATORY, SUCH A PROCESS INCLUDES THE FOLLOWING STEPS OF A SIGNIFICANT DRAFT IDENTIFICATION. SINGLE COMPONENTS (IN 1 SINGLE STEP) OR THROUGH MULTI-COMPONENT REACTIONS (IN 2 OR 3 STEPS),
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES9101471A ES2042371B1 (en) | 1991-06-20 | 1991-06-20 | PROCESS AND EQUIPMENT FOR THE DETECTION OF STORAGE DRUGS IN DRUG TRAFFICKING. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES9101471A ES2042371B1 (en) | 1991-06-20 | 1991-06-20 | PROCESS AND EQUIPMENT FOR THE DETECTION OF STORAGE DRUGS IN DRUG TRAFFICKING. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2042371A1 ES2042371A1 (en) | 1993-12-01 |
| ES2042371B1 true ES2042371B1 (en) | 1994-07-01 |
Family
ID=8272755
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES9101471A Expired - Fee Related ES2042371B1 (en) | 1991-06-20 | 1991-06-20 | PROCESS AND EQUIPMENT FOR THE DETECTION OF STORAGE DRUGS IN DRUG TRAFFICKING. |
Country Status (1)
| Country | Link |
|---|---|
| ES (1) | ES2042371B1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL1007402C2 (en) * | 1997-10-30 | 1999-05-04 | Jan Willem Ewoud Vijfwinkel | Reagent for qualitative determination of phenethyl:amine derivatives |
| ES2162729B1 (en) * | 1999-05-13 | 2003-06-16 | Hernandez Tudela Bernardo | UNIVERSAL TEAM FOR DRUG DETECTION |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4104027A (en) * | 1977-11-21 | 1978-08-01 | Carroll Robert B | Process for the presumptive identification of narcotics and drugs of abuse |
| FR2629915B1 (en) * | 1988-04-08 | 1992-10-23 | Lefel Marie France | METHOD FOR DETECTING TRACES OF NARCOTICS AND PRODUCTS FOR CARRYING OUT SAID METHOD |
-
1991
- 1991-06-20 ES ES9101471A patent/ES2042371B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2042371A1 (en) | 1993-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Schramm et al. | Drugs of abuse in saliva: a review | |
| ES2104566T3 (en) | REAGENTS FOR THE DETERMINATION OF DRUGS. | |
| BR9910404A (en) | Transdermal therapeutic system (tts) for transcutaneous administration of pergolide for several days with a means of fixing the tts on the skin | |
| ES2051112T3 (en) | SITE TO INJECT. | |
| HUP9702307A2 (en) | Preparation suitable for antigen release | |
| TR200002159T2 (en) | Topical compositions for administration of NSAI drugs. | |
| Kamath et al. | Determination of diclofenac sodium, famotidine and ketorolac tromethamine by flow injection analysis using dichloronitrophenol | |
| Compton | Field evaluation of the Los Angeles Police Department drug detection program | |
| Jones et al. | Benzodiazepines identified by capillary gas chromatography-mass spectrometry, with specific ion screening used to detect benzophenone derivatives. | |
| ES2042371B1 (en) | PROCESS AND EQUIPMENT FOR THE DETECTION OF STORAGE DRUGS IN DRUG TRAFFICKING. | |
| KR860007314A (en) | Vulcanized Rubber Composition | |
| ES2031497T3 (en) | PROCEDURE AND TEST EQUIPMENT FOR THE DETECTION OF DRUGS. | |
| KR850004341A (en) | Indicator tube | |
| Vlachoyiannopoulos et al. | Chorea as a manifestation of the antiphospholipid syndrome in childhood | |
| ARITA et al. | Transformation and Excretion of Drugs in Biological Systems. III. Separatory Determination of Metoclopramide and Its N4-Glucuronide and N4-Sulfonate in Rabbit Urine and Bile | |
| Roman et al. | N-methyl-D-aspartate receptor complex modulation by neuropeptide Y and peptide YY in rat hippocampus in vitro | |
| McFadden et al. | Contact allergy to cane reed in a clarinettist. | |
| MacDonald | Dun & Bradstreet business microdata research applications, and the detection and correction of errors. | |
| KR850007366A (en) | Sustained Granular Pesticides | |
| Sancilio et al. | Application of sequential analysis to Evans Blue-carrageenan-induced pleural effusion for screening compounds for anti-inflammatory activity | |
| Merritt et al. | PH Effects on Chloroform Extraction of Drugs of Abuse from Urine. | |
| Tunnicliff et al. | Competitive inhibition of γ‐aminobutyric acid synaptosomal uptake by 4‐(4′‐azidobenzoimidylamino) butanoic acid | |
| Knauf et al. | Evaluation of Explosives/Narcotics (EXNARC) Detection Dogs. | |
| Pechnick et al. | Naloxone does not antagonize PCP-induced stimulation of the pituitary-adrenal axis in the rat | |
| Boudene et al. | Application of radioimmunoassay for testosterone to routine testing |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD2A | Announcement of lapse in spain |
Effective date: 20111201 |